The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-Methoxyphenyl)-N-methyl-5-m-tolylthiophene-2-carboxamide ID: ALA2324690
PubChem CID: 60196704
Max Phase: Preclinical
Molecular Formula: C20H19NO2S
Molecular Weight: 337.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cccc(N(C)C(=O)c2ccc(-c3cccc(C)c3)s2)c1
Standard InChI: InChI=1S/C20H19NO2S/c1-14-6-4-7-15(12-14)18-10-11-19(24-18)20(22)21(2)16-8-5-9-17(13-16)23-3/h4-13H,1-3H3
Standard InChI Key: BABRITZRSIMSNK-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
4.5508 -5.5723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7310 -5.4858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4030 -6.2213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0125 -6.7753 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.7169 -6.3708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2771 -6.6302 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2789 -7.4533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9817 -7.8591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6914 -7.4512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6937 -6.6293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9822 -6.2231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4653 -6.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1305 -6.2206 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8790 -6.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0433 -5.4076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9650 -7.3692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7126 -7.7028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3744 -7.2208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2876 -6.4058 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5441 -6.0718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5508 -7.5169 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.5689 -6.2224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9455 -5.9280 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8609 -5.1152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 1 2 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
10 3 1 0
5 12 1 0
12 13 1 0
13 14 1 0
13 15 1 0
14 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 14 1 0
12 21 2 0
6 22 1 0
23 24 1 0
19 23 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 337.44Molecular Weight (Monoisotopic): 337.1136AlogP: 5.01#Rotatable Bonds: 4Polar Surface Area: 29.54Molecular Species: NEUTRALHBA: 3HBD: ┄#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.84CX LogD: 4.84Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.67Np Likeness Score: -1.57
References 1. Marchais-Oberwinkler S, Xu K, Wetzel M, Perspicace E, Negri M, Meyer A, Odermatt A, Möller G, Adamski J, Hartmann RW.. (2013) Structural optimization of 2,5-thiophene amides as highly potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors for the treatment of osteoporosis., 56 (1): [PMID:23145773 ] [10.1021/jm3014053 ] 2. Perspicace E, Cozzoli L, Gargano EM, Hanke N, Carotti A, Hartmann RW, Marchais-Oberwinkler S.. (2014) Novel, potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors as potential therapeutics for osteoporosis with dual human and mouse activities., 83 [PMID:24974351 ] [10.1016/j.ejmech.2014.06.036 ] 3. Gargano EM, Perspicace E, Hanke N, Carotti A, Marchais-Oberwinkler S, Hartmann RW.. (2014) Metabolic stability optimization and metabolite identification of 2,5-thiophene amide 17β-hydroxysteroid dehydrogenase type 2 inhibitors., 87 [PMID:25259513 ] [10.1016/j.ejmech.2014.09.061 ]